Latest: FDA Approves New Biosimilar for Oncology Treatment

FriskaAi Integrates with Dexcom’s CGM Data for AI-Powered Diabetes Management

0 Mins
What You Should Know: – FriskaAi, an AI-powered healthcare platform, has announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into its platform. – The collaboration will enable FriskaAi to use continuous glucose data to support physicians and ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago